Abstract |
High discontinuation rates for depot medroxyprogesterone acetate ( DMPA) in adolescents may contribute to the number of unintended pregnancies. Many cite vaginal bleeding as a reason for discontinuing DMPA use. In this study, we attempted to determine if treating DMPA-associated vaginal bleeding with monophasic oral contraceptive pills (OCP) raised continuation rates. A total of 131 patients who reported vaginal bleeding while on DMPA were included in this study and 83 were treated with monophasic OCP. Of those who received OCP, 38.7% reported that vaginal bleeding stopped completely, 51.8% reported that vaginal bleeding stopped temporarily, and 6.0% reported no change. Overall, 94% of enrolled patients who received OCP as a treatment for DMPA-associated vaginal bleeding continued DMPA use. Our findings indicate that vaginal bleeding due to DMPA can be successfully treated, leading to improvement in continuation rates.
|
Authors | Kristin M Rager, Amy Fowler, Hatim A Omar |
Journal | TheScientificWorldJournal
(ScientificWorldJournal)
Vol. 6
Pg. 353-5
(Mar 19 2006)
ISSN: 1537-744X [Electronic] United States |
PMID | 16547584
(Publication Type: Journal Article)
|
Chemical References |
- Contraceptive Agents, Female
- Contraceptives, Oral, Hormonal
- Medroxyprogesterone Acetate
|
Topics |
- Adolescent
- Adult
- Contraceptive Agents, Female
(adverse effects, therapeutic use)
- Contraceptives, Oral, Hormonal
(therapeutic use)
- Female
- Humans
- Medroxyprogesterone Acetate
(adverse effects, therapeutic use)
- Metrorrhagia
(chemically induced, drug therapy)
- Patient Compliance
- Pregnancy
- Pregnancy in Adolescence
(prevention & control)
- Retrospective Studies
|